Venus Remedies Limited
Venus Remedies Ltd recommended a final dividend of Rs.10 per equity share for the financial year 2025-26. The record date for the dividend is August 7, 2026, with payment expected by September 18, 2026, after shareholder approval at the AGM on August 20, 2026.
May 26 2026 22:36:21
Venus Remedies Limited
Venus Remedies Ltd recommended a final dividend of Rs.10 per equity share for the financial year 2025-26. The record date for the dividend is August 7, 2026, with payment expected by September 18, 2026, after shareholder approval at the AGM on August 20, 2026.
May 26 2026 22:35:35
Venus Remedies Ltd - 526953 - Adoption Of MOA & AOA As Per The Companies Act 2013
Venus Remedies board approved several key leadership appointments. Mr. Saransh Chaudhary was appointed as Whole Time Director for five years from May 26, 2026. Dr. (Mrs.) Manu Chaudhary was reappointed as Joint Managing Director for five years from October 1, 2026. Both are subject to shareholder approval.
May 26 2026 22:12:45
Venus Remedies Ltd - 526953 - Announcement under Regulation 30 (LODR)-Change in Management
Venus Remedies appointed Mr. Saransh Chaudhary as Whole Time Director and re-appointed Dr. Manu Chaudhary as Joint Managing Director, both for five-year terms. The board also approved the appointments of two Non-Executive Independent Directors.
May 26 2026 22:08:57
Venus Remedies Ltd - 526953 - Venus Remedies Receives Saudi FDA Approval For Plerixafor - Its First Maketing Authorization For The Specialty Oncology Therapy Globally
Venus Remedies received Saudi FDA approval for Plerixafor, its first global marketing authorization for the specialty oncology therapy. This approval allows the company to commercialize the drug in Saudi Arabia, a key market for high-value specialty injectables.
May 22 2026 11:54:13
Venus Remedies Ltd - 526953 - Corporate Action-Board to consider Dividend
Venus Remedies board scheduled a meeting for May 26, 2026. The agenda includes consideration for a final dividend recommendation for FY26. Post-meeting, the board's decision on the dividend will be announced.
May 15 2026 15:32:40
Venus Remedies Ltd - 526953 - Board Meeting Intimation for Board Meeting Scheduled For 26Th May 2026.
Venus Remedies' Board of Directors will convene on May 26, 2026, to discuss and approve the audited financial results for the quarter and fiscal year ending March 31, 2026. They will also consider recommending a final dividend for the same period.
May 15 2026 15:28:45
Read More